<div id="readability-page-1">Eli Lilly and Company (NYSE:LLY) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. Eli Lilly and Company (NYSE:LLY) is moving quickly to lock in its position in India’s fast-growing obesity drug market. Cheaper generic versions are expected to arrive as early as March next year, and the window to build […]</div>

禮來

<p>禮來公司（NYSE:LLY）正在迅速在印度蓬勃發展的肥胖藥物市場中建立其存在。該公司還被列為 2026 年值得購買的 14 只最佳製藥股之一。隨着預計在明年 3 月之前將有更便宜的仿製藥進入市場，禮來旨在在這一潮流到來之前確保其競爭優勢</p>

禮來（LLY）迅速採取行動，以確保在印度肥胖症藥物市場的領先地位